<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

1 min read

Center for Definitive & Curative Medicine - CDCM 7th Annual Symposium

Center for Definitive & Curative Medicine - CDCM 7th Annual Symposium

Date: March 15, 2023 | 8:00 a.m. - 5:30 p.m. PDT

Location: Stanford University School Medicine - Directions

Event Website: https://med.stanford.edu/cdcm/events/7th-annual-cdcm-symposium.html


Join us for our live presentation!

Maggie Chen, AGC Biologics' Sr. Director of Manufacturing, will be presenting during this event on the advancements in cell and gene therapies. We hope you'll join us at this amazing event to explore new discoveries in regenerative medicine and clinical trials in this one-day conference.

Click the link above to get all the details. 



You can also reach out directly to our experts attending the Symposium

Maggie Chen
Sr. Director, Manufacturing
Email  me
Raghu Malapaka
Sr. Director, Business Development - Cell & Gene Therapy
Email  me

Learn about our cell and gene therapy services 

Cell Therapy Production and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Learn more about our overall cell therapy offering 

Viral Vector Production and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Discover more about our viral vector services 

Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Learn more about our Plasmid offering

Fill out the form below to request a meeting during the event


ESGCT 30th Annual Congress, October 24-27

ESGCT 30th Annual Congress, October 24-27

CPHI Barcelona, October 24-26

CPHI Barcelona, October 24-26

BioJapan, October 11-13

BioJapan, October 11-13